PUBLISHED DATE : Feb 2023 | Pages : 289
Fill out your details & get your free sample
The Parenteral Nutrition Market Size, Share, & Trends Analysis Report By
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027
289 Pages
113 Tables
126 Charts
5 Regions
18 Countries
21 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (2027) | USD 10.70 Billion |
| MARKET SIZE (2021) | USD 7.18 Billion |
| CAGR (2021-2027) | 6.88% |
| BASE YEAR | 2021 |
| FORECAST YEAR | 2022-2027 |
| SEGMENTS BY | Nutrients, Indication, Patient Group, End-user, and Geography |
| GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY PLAYERS | Baxter, B. Braun Melsungen, Fresenius Kabi, JW Pharmaceuticals, and Sichuan Kelun Pharmaceuticals |
The global parenteral nutrition market crossed USD 7.18 billion in 2021 and is expected to reach USD 10.70 billion by 2027, growing at a CAGR of 6.88% during the forecast period. The increasing poverty at a global level and concern about nutritional health are the major factors that demand the parenteral nutrition supply. The factors that drive the market growth are increasing malnutrition in general and hospitalized patients. Malnutrition is a growing concern that requires a parenteral nutrition supply. The major targeted population is hospitalized patients, preterm birth, cancer patient, and other diseases that demand parenteral nutrition and gives a boost to the market growth at the global market.
Parenteral nutrition is also called the intravenous administration of nutrition, which includes carbohydrates, proteins, fat, electrolytes, mineral, fat, vitamins, water, and other trace elements. Parenteral nutrition (PN) is used to deliver nutritional supply to patients who cannot tolerate enteral or oral nutrition delivery. There are two types of parenteral nutrition: total and partial parenteral. Depending on the patient's conditions and nutritional health status, the patient can receive total or partial parenteral nutrition in healthcare settings.
Globally, the increasing concern about nutritional health due to the changing lifestyle of the people, the increasing need for nutritional support to achieve a healthy life, and economical, social, and environmental factors majorly drive the parenteral nutrition market landscape. Further, the parenteral nutrition market is growing rapidly with innovations and advancements. The vendors in the market are looking for more inorganic growth methods. In 2020, the leading market player Baxter International, well known for its clinical nutrition (including parenteral nutrition solutions), made a joint venture with VIPUN Medical, a pioneer in developing technology. This joint venture help in improves the medical nutrition segment. The company announced the agreement to commercialize the VIPUN gastric monitoring system, which is used for patients intolerant to enteral nutrition; Baxter’s parenteral nutrition products help to ensure the patient gets nutritional needs.
Availability of Standardized and Commercial Parenteral Nutrition Solutions
The increasing demand for personalized and commercial medicine in the healthcare industry is a growing trend addressed in recent years. The growing preference for standardized and commercial parenteral nutrition solutions gives a new shape to the parenteral nutrition market.
Standardized parenteral nutrition products are convenient and flexible for healthcare services it can be given to patients without compounding in-house. Standardized and commercial parenteral nutrition products can be sourced as institution-specific standardized formulations, patient-specific customized, or commercially available products. The demand for standardized and commercial parenteral nutrition has been increasing in recent years due to beneficiaries associated with the products. These solutions offer several advantages to healthcare organizations, including stability & compatibility and minimal manipulation.
Increasing Targeted Patient Population
Parenteral nutrition treats and manages various chronic conditions, malnourished patient populations, and emergency medical conditions. Worldwide, the increasing patient population drives the demand for nutritional support in healthcare services such as hospitals, clinics, and home care settings. Globally, the increasing prevalence of chronic conditions is one of the major factors that drive the significant demand for hospitalization where patients demand nutritional support due to the increasing illness or inability to meet the nutritional demand. On another side, the increasing poverty led to various medical conditions and demand for parenteral conditions.
Cancer is one of the leading causes of death accounted for at the global level. In 2020, more than 18 million cancer cases were registered worldwide. Among cancer patients, malnutrition is a common condition that requires external nutrition support. Around 1.8 million people with cancer die just due to malnutrition. The higher prevalence of malnutrition among cancer patients drives the parenteral nutrition market growth.
Complications Associated with Parenteral Nutrition
Parenteral nutrition is a complex procedure to feed the external nutritional support for the patients. Most hospitalized patients receive parenteral nutrition due to the hospital's associated malnutrition and medical condition. Both factors are challenging for parenteral nutrition delivery. The most vital complication of parenteral nutrition support is the failure to achieve the desired goals due to inadequate monitoring. Due to the higher risk of complications associated with parenteral nutrition, it is given less prominence than enteral nutrition, which hampers the parenteral nutrition market growth. The primary and major concerns related to parenteral nutrition are infection of the bloodstream from the atrophy of the digestive tract when it isn’t being used and IV catheter.
SEGMENTATION INSIGHTS
INSIGHTS BY NUTRIENTS
The global parenteral nutrition market is segmented into macronutrients, automated compounds, and micronutrients by the nutrient category. The macronutrients segment accounted for a 66.65% higher market share in the parenteral nutrition market and dominated the other segment in 2021. Macronutrients include lipids and amino acids. Lipids and amino acids are majorly used ingredients in parenteral nutrition solutions as energy-dese solutions and support body function and rapidly improve body physics. Lipids and amino acids are used in parenteral nutrition as per their characteristics in improving nutritional health through parenteral nutrition. Moreover, the maximum number of products available in the market by manufacturers and market players are based on macronutrients, which further accelerates the macronutrient segment growth.
The global parenteral nutrition market by automated compounds was valued at USD 1.35 billion in 2021. The advancement in automated compounds in parenteral nutrition recently becomes more popular in pediatric parenteral nutrition. Parenteral nutrition compounding is automated using volumetric pump systems in major hospitals and healthcare settings. In most US hospitals and healthcare settings, more than 65% of hospitals use automated compounding devices.
INSIGHTS BY PATIENT TYPE
The parenteral nutrition market is segmented into the pediatric and adult segment by patient type. The pediatric segment accounts for a 55.05% major market share and is expected to dominate the adult segment during the forecast period. The significant number of the targeted preterm patient population, rising low birth weight concern, and malnutrition fuel the demand for parenteral nutrition supply over the adults. In addition, the advancement in trace elements and new products for pediatric parenteral nutrition accelerates segmental growth.
INSIGHTS BY INDICATION
The global parenteral nutrition market is segmented into short-term and long-term segments by indication. The short-term segment dominates the market with a 55.41% higher share. Globally, the increasing prevalence of cancer, metabolic disorders, gut failure, and malnutrition significantly drive the demand for healthcare services and receiving parenteral nutrition.
By long-term indication, the global parenteral nutrition market was valued at USD 3.20 billion in 2021. Long-term parenteral nutrition is a highly demanding medical nutrition therapy delivered through the intravenous route for a long time as per the patient’s requirement. With the increasing prevalence of gastrointestinal disorders, patients go through several medications and treatments that impact the digestive system's functional ability and demand for parenteral nutrition. The recovery from digestive system injury or surgery takes significant time to get normal health and drives the high demand for long-term parenteral nutrition supply.
INSIGHTS BY END USER
The hospital segment accounted for a 47.57% share of the parenteral nutrition market in 2021 and dominated the end-user segment. The rising prevalence of malnutrition, diseases-related malnutrition, and hospital-associated malnutrition conditions significantly demand parenteral nutrition. Hospitals are a primary and well-established infrastructure for a longer stay if the patient suffers from any medical condition or procedure illness. Baxter, the leading industry player, stated that around 2 million approximated hospitals in the US involve in malnutrition prevalence.
The global parenteral nutrition market by ambulatory care settings was valued at USD 3.13 billion in 2021. In the ambulatory care settings segment, clinics and external healthcare services are included. In developing countries or emerging markets, malnutrition poses a significant cost burden on patients. So patients looking to avoid long hospital stays opt for other healthcare settings. In such a scenario, clinics and ambulatory care settings play a vital role in parenteral nutrition deliveries. Clinical nutrition is a major part of healthcare services for patients suffering from chronic illness. Also, the high-cost burden in a hospital setting for parenteral nutrition deliveries and longer stays change the patient preference for care to ambulatory care settings.
North America dominates the global parenteral nutrition market accounting for an industry share of 41.05%. The factors that drive the industry growth in the region are the high research expenditure by the companies, government authorities, and private entities in the nutrition sector that give the region significant access to parenteral nutrition services. In addition, the high healthcare expenditure and acceptance of home parenteral and other nutrition therapies across the US anticipated higher parenteral nutrition market growth in the region.
APAC's parenteral nutrition market was valued at USD 2.09 billion in 2021. The region is a growing parenteral nutrition market with an increasingly aging population, research and development in clinical nutrition, and regional healthcare infrastructure growth. The prevalence of chronic disorders such as cancer, diabetes, gastrointestinal disorders, kidney failure, and cardiovascular diseases showed that the region's highest patient population demands care services and drives the parenteral nutrition market.
The Europe parenteral nutrition market is growing at a CAGR of 6.38% during the forecast period. In Europe, the parenteral nutrition market shows rapid progressive growth as the increasing influence of industry players, the rising focus on parenteral nutrition deliveries by government and healthcare authorities, and a stable economy. The European Society for Clinical Nutrition and Metabolism (ESPEN) is the leading organization in the parenteral and enteral nutrition field, which support and promotes basic research, advanced education, and awareness about clinical care and care quality control.
Baxter, B. Braun Melsungen, Baxter, Fresenius Kabi, JW Pharmaceutical, and Kelun Pharmaceuticals are some of the leading players in the parenteral nutrition market. These companies account for the higher market share and show high industry penetration by offering advanced and quality solutions. On the other hand, emerging industry players and new start-ups are trying to achieve a solid customer base and market expansion. The presence of emerging industry players positively influences the competition in the global parenteral nutrition market. The primary competition among the industry players accounted due to new product launches, emerging, and gold standard formulations.
Braun Melsungen is a leading player in the global parenteral nutrition market. On another side, the Fresenius Kabi pioneers in parenteral nutrition (administered intravenously) and enteral nutrition (administered as tube feed, sip, or gastrointestinal tract). Baxter is one of the leading suppliers of the essential ingredients important to developing well-balanced formulations of parenteral nutrition regimens. Baxter offers accessible and innovative solutions and services designed to be used in various healthcare environments, such as hospitals, ICUs, clinics, nursing homes, and home care settings in the parenteral nutrition market. Also, the company supplies essential ingredients to develop well-balanced formulations of medical nutrition regimens.
Frequently Asked Questions
How big is the parenteral nutrition market?
The global parenteral nutrition market size was valued at USD 7.18 billion in 2021 and is expected to reach USD 10.70 billion by 2027.
What is the growth rate of the global parenteral nutrition market?
The global parenteral nutrition market share is expected to grow at a CAGR of 6.88% from 2021 to 2027.
Which region holds the most prominent global parenteral nutrition market share?
In 2021, the North American region accounted for a significant 41.05% parenteral nutrition market share and dominated the other regions. The factors that propel the market growth in the region are the increasing R&D on parenteral nutrition solutions and associated expenditure, major government initiatives with increasing concern about malnutrition giving the region significant access to parenteral nutrition services.
Who are the key players in the global parenteral nutrition market?
Baxter, B. Braun Melsungen, Fresenius Kabi, JW Pharmaceuticals, and Sichuan Kelun Pharmaceuticals are the key players in the global parenteral nutrition market.
What are the key driving factors for the growth of the parenteral nutrition market?
The advancement in supplementation of trace elements parenteral nutrition, availability of standardized and commercial parenteral nutrition solutions, and the growing preference towards home parenteral nutrition are key factors driving the parenteral nutrition market growth.
The global parenteral nutrition market is expected to grow at a CAGR of approximately 6.88% from 2021 to 2027.
The following factors are likely to contribute to the growth of the global parenteral nutrition market during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the global parenteral nutrition market and its market dynamics for 2022−2027. It covers a detailed overview of several industry growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Company Profiles
Other Prominent Vendors
Segmentation by Nutrients
Segmentation by Indication
Segmentation by Patient Group
Segmentation by End-users
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET BY NUTRIENTS
4.3.2 MARKET BY INDICATION
4.3.3 MARKET BY PATIENT GROUP
4.3.4 MARKET BY END-USERS
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
7.1.1 ECONOMIC IMPACT OF MALNUTRITION & GROWTH OF PARENTERAL NUTRITION
8 PREMIUM INSIGHTS
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 ADVANCES IN TRACE ELEMENTS FOR PARENTERAL NUTRITION
9.2 AVAILABILITY OF STANDARDIZED AND COMMERCIAL PARENTERAL NUTRITION SOLUTIONS
9.3 GROWTH IN PREFERENCE FOR HOME PARENTERAL NUTRITION
10 MARKET GROWTH ENABLERS
10.1 INCREASING PREVALENCE OF CHRONIC DISORDERS
10.2 INCREASING PREVALENCE OF MALNUTRITION
10.3 INCREASING TARGET PATIENT POPULATION
11 MARKET RESTRAINTS
11.1 PARENTERAL NUTRITION CHALLENGES IN PRETERM INFANTS AND CHILDREN
11.2 AVAILABILITY OF ALTERNATIVE NUTRITION CARE METHODS
11.3 COMPLICATIONS ASSOCIATED WITH PARENTERAL NUTRITION
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 NUTRIENTS INSIGHTS
12.1.2 PATIENT GROUP INSIGHTS
12.1.3 INDICATION INSIGHTS
12.1.4 END-USERS INSIGHTS
12.1.5 GEOGRAPHY INSIGHTS
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 NUTRIENTS
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 MACRONUTRIENTS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 AUTOMATED COMPOUNDS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 MICRONUTRIENTS
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
14 INDICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 SHORT-TERM
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 LONG-TERM
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
15 PATIENT GROUP
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.1 PEDIATRIC
15.1.1 MARKET OVERVIEW
15.1.2 MARKET SIZE & FORECAST
15.1.3 MARKET BY GEOGRAPHY
15.2 ADULT
15.2.1 MARKET OVERVIEW
15.2.2 MARKET SIZE & FORECAST
15.2.3 MARKET BY GEOGRAPHY
16 END-USERS
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 HOSPITALS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 AMBULATORY CARE SETTINGS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 OTHERS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 NUTRIENTS
18.3.1 MARKET SIZE & FORECAST
18.4 INDICATION
18.4.1 MARKET SIZE & FORECAST
18.5 PATIENT GROUP
18.5.1 MARKET SIZE & FORECAST
18.6 END-USERS
18.6.1 MARKET SIZE & FORECAST
18.7 KEY COUNTRIES
18.7.1 US: MARKET SIZE & FORECAST
18.7.2 CANADA: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 NUTRIENTS
19.3.1 MARKET SIZE & FORECAST
19.4 INDICATION
19.4.1 MARKET SIZE & FORECAST
19.5 PATIENT GROUP
19.5.1 MARKET SIZE & FORECAST
19.6 END-USERS
19.6.1 MARKET SIZE & FORECAST
19.7 KEY COUNTRIES
19.7.1 CHINA: MARKET SIZE & FORECAST
19.7.2 JAPAN: MARKET SIZE & FORECAST
19.7.3 INDIA: MARKET SIZE & FORECAST
19.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
19.7.5 AUSTRALIA: MARKET SIZE & FORECAST
20 EUROPE
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 NUTRIENTS
20.3.1 MARKET SIZE & FORECAST
20.4 INDICATION
20.4.1 MARKET SIZE & FORECAST
20.5 PATIENT GROUP
20.5.1 MARKET SIZE & FORECAST
20.6 END-USERS
20.6.1 MARKET SIZE & FORECAST
20.7 KEY COUNTRIES
20.7.1 GERMANY: MARKET SIZE & FORECAST
20.7.2 FRANCE: MARKET SIZE & FORECAST
20.7.3 UK: MARKET SIZE & FORECAST
20.7.4 ITALY: MARKET SIZE & FORECAST
20.7.5 SPAIN: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 NUTRIENTS
21.3.1 MARKET SIZE & FORECAST
21.4 INDICATION
21.4.1 MARKET SIZE & FORECAST
21.5 PATIENT GROUP
21.5.1 MARKET SIZE & FORECAST
21.6 END-USERS
21.6.1 MARKET SIZE & FORECAST
21.7 KEY COUNTRIES
21.7.1 BRAZIL: MARKET SIZE & FORECAST
21.7.2 MEXICO: MARKET SIZE & FORECAST
21.7.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 NUTRIENTS
22.3.1 MARKET SIZE & FORECAST
22.4 INDICATION
22.4.1 MARKET SIZE & FORECAST
22.5 PATIENT GROUP
22.5.1 MARKET SIZE & FORECAST
22.6 END-USERS
22.6.1 MARKET SIZE & FORECAST
22.7 KEY COUNTRIES
22.7.1 TURKEY: MARKET SIZE & FORECAST
22.7.2 SOUTH AFRICA: MARKET SIZE & FORECAST
22.7.3 SAUDI ARABIA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
23.2.1 BAXTER
23.2.2 B. BRAUN MELSUNGEN
23.2.3 FRESENIUS KABI
23.2.4 JW PHARMACEUTICAL
23.2.5 SICHUAN KELUN PHARMACEUTICAL CO., LTD.
24 KEY COMPANY PROFILES
24.1 BAXTER
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 B. BRAUN MELSUNGEN
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.2.3 KEY STRATEGIES
24.2.4 KEY STRENGTHS
24.2.5 KEY OPPORTUNITIES
24.3 FRESENIUS KABI
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.3.3 KEY STRATEGIES
24.3.4 KEY STRENGTHS
24.3.5 KEY OPPORTUNITIES
24.4 JW PHARMACEUTICAL
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.4.3 KEY STRATEGIES
24.4.4 KEY STRENGTHS
24.4.5 KEY OPPORTUNITIES
24.5 SICHUAN KELUN PHARMACEUTICAL CO., LTD.
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.5.3 KEY STRATEGIES
24.5.4 KEY STRENGTHS
24.5.5 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 ACULIFE
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 ALBERT DAVID
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 AMANTA HEALTHCARE
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 AMERICAN REAGENT
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 BML PARENTERAL DRUGS
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 CARITAS HEALTHCARE
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 EUROFARMA
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 EUROLIFE HEALTHCARE
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 FARMOTERAPICA
25.9.1 BUSINESS OVERVIEW
25.9.2 PRODUCT OFFERINGS
25.10 GRIFOLS S.A.
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 ICU MEDICAL
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 OTSUKA PHARMACEUTICAL
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 SOLEO HEALTH
25.13.1 BUSINESS OVERVIEW
25.13.2 PRODUCT OFFERINGS
25.14 REVIV
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
25.15 PFIZER
25.15.1 BUSINESS OVERVIEW
25.15.2 PRODUCT OFFERINGS
25.16 VIFOR PHARMA
25.16.1 BUSINESS OVERVIEW
25.16.2 PRODUCT OFFERINGS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY GEOGRAPHY
27.2 MARKET BY NUTRIENTS
27.3 MARKET BY INDICATION
27.4 MARKET BY PATIENT GROUP
27.5 MARKET BY END-USER
27.6 NUTRIENTS: MARKET BY GEOGRAPHY
27.6.1 MACRONUTRIENTS: MARKET BY GEOGRAPHY
27.6.2 AUTOMATED COMPOUNDS: MARKET BY GEOGRAPHY
27.6.3 MICRONUTRIENTS: MARKET BY GEOGRAPHY
27.7 INDICATION: MARKET BY GEOGRAPHY
27.7.1 SHORT-TERM: MARKET BY GEOGRAPHY
27.7.2 LONG-TERM: MARKET BY GEOGRAPHY
27.8 PATIENT GROUP: MARKET BY GEOGRAPHY
27.8.1 PEDIATRIC: MARKET BY GEOGRAPHY
27.8.2 ADULT: MARKET BY GEOGRAPHY
27.9 END-USERS: MARKET BY GEOGRAPHY
27.9.1 HOSPITALS: MARKET BY GEOGRAPHY
27.9.2 AMBULATORY CARE CENTERS: MARKET BY GEOGRAPHY
27.9.3 OTHERS: MARKET BY GEOGRAPHY
28 APPENDIX
28.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL PARENTERAL NUTRITION MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 CONDITIONS THAT REQUIRE PARENTERAL NUTRITION
EXHIBIT 4 ECONOMIC IMPACT OF MALNUTRITION & GROWTH OF PARENTERAL NUTRITION
EXHIBIT 5 EUROPEAN COUNTRIES: ESTIMATED FINANCIAL COST IMPLICATION OF MALNUTRITION
EXHIBIT 6 GLOBAL PARENTERAL NUTRITION MARKET SEGMENTATION
EXHIBIT 7 IMPACT OF ADVANCES IN TRACE ELEMENTS FOR PARENTERAL NUTRITION
EXHIBIT 8 IMPACT OF AVAILABILITY OF STANDARDIZED AND COMMERCIAL PARENTERAL NUTRITION SOLUTIONS
EXHIBIT 9 BENEFITS OF COMMERCIALLY AVAILABLE STANDARDIZED PARENTERAL NUTRITION PRODUCTS
EXHIBIT 10 IMPACT OF GROWTH IN PREFERENCE FOR HOME PARENTERAL NUTRITION
EXHIBIT 11 ADVANCES IN CATHETERS AND THEIR ADVANTAGES IN HOME PARENTERAL NUTRITION
EXHIBIT 12 IMPACT OF INCREASING PREVALENCE OF CHRONIC DISORDERS
EXHIBIT 13 GASTROINTESTINAL DISORDERS THAT REQUIRE PARENTERAL NUTRITION
EXHIBIT 14 IMPACT OF INCREASING PREVALENCE OF MALNUTRITION
EXHIBIT 15 DISEASES RELATED TO MALNUTRITION AND IMPACT
EXHIBIT 16 IMPACT OF INCREASING TARGET PATIENT POPULATION
EXHIBIT 17 TARGETED PATIENT POPULATION FOR PARENTERAL NUTRITION 2019
EXHIBIT 18 IMPACT OF PARENTERAL NUTRITION CHALLENGES IN PRETERM INFANTS AND CHILDREN
EXHIBIT 19 IMPACT OF AVAILABILITY OF ALTERNATIVE NUTRITION CARE METHODS
EXHIBIT 20 IMPACT OF COMPLICATIONS ASSOCIATED WITH PARENTERAL NUTRITION
EXHIBIT 21 PARENTERAL NUTRITION COMPLICATION RATE
EXHIBIT 22 COMPLICATIONS ASSOCIATED WITH PARENTERAL NUTRITION
EXHIBIT 23 GLOBAL PARENTERAL NUTRITION MARKET SEGMENTATION
EXHIBIT 24 GLOBAL PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021 & 2027 (%)
EXHIBIT 25 GLOBAL PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021 & 2027 (%)
EXHIBIT 26 GLOBAL PARENTERAL NUTRITION MARKET BY INDICATION 2021 & 2027 (%)
EXHIBIT 27 GLOBAL PARENTERAL NUTRITION MARKET BY END-USERS 2021 & 2027 (%)
EXHIBIT 28 GLOBAL PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021 & 2027 (%)
EXHIBIT 29 GLOBAL PARENTERAL NUTRITION MARKET 2021–2027 ($ BILLION)
EXHIBIT 30 FIVE FORCES ANALYSIS 2021
EXHIBIT 31 INCREMENTAL GROWTH BY NUTRIENTS 2021 & 2027
EXHIBIT 32 GLOBAL PARENTERAL NUTRITION BY NUTRIENTS −
EXHIBIT 33 GLOBAL PARENTERAL NUTRITION MARKET BY NUTRIENTS: MARKET OVERVIEW
EXHIBIT 34 GLOBAL PARENTERAL NUTRITION MARKET BY NUTRIENTS: INCREMENTAL GROWTH
EXHIBIT 35 GLOBAL PARENTERAL NUTRITION MARKET BY NUTRIENTS: ABSOLUTE GROWTH
EXHIBIT 36 GLOBAL PARENTERAL NUTRITION MARKET BY MACRONUTRIENTS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 37 GLOBAL PARENTERAL NUTRITION MARKET BY MACRONUTRIENTS 2021−2017 ($ BILLION)
EXHIBIT 38 GLOBAL PARENTERAL NUTRITION MARKET BY AUTOMATED COMPOUNDS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 39 GLOBAL PARENTERAL NUTRITION MARKET BY AUTOMATED COMPOUNDS 2021-2017 ($ BILLION)
EXHIBIT 40 RECOMMEND AMOUNT OF TRACE ELEMENTS ROUTINELY INCLUDES PARENTERAL NUTRITION 2019
EXHIBIT 41 TIMELINE OF DEVELOPMENT OF CURRENT US RECOMMENDATION FOR DOSING TRACE ELEMENTS (PN: PARENTERAL NUTRITION)
EXHIBIT 42 GLOBAL PARENTERAL NUTRITION MARKET BY MICRONUTRIENTS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL PARENTERAL NUTRITION MARKET BY MICRONUTRIENTS 2021−2017 ($ BILLION)
EXHIBIT 44 INCREMENTAL GROWTH BY INDICATION 2021 & 2027
EXHIBIT 45 GLOBAL PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027
EXHIBIT 46 GLOBAL PARENTERAL NUTRITION MARKET BY INDICATION: MARKET OVERVIEW
EXHIBIT 47 GLOBAL PARENTERAL NUTRITION MARKET BY INDICATION: INCREMENTAL GROWTH
EXHIBIT 48 GLOBAL PARENTERAL NUTRITION MARKET BY INDICATION: ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL PARENTERAL NUTRITION MARKET BY SHORT-TERM: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 50 GLOBAL PARENTERAL NUTRITION MARKET BY SHORT-TERM 2021−2017 ($ BILLION)
EXHIBIT 51 GLOBAL PARENTERAL NUTRITION MARKET BY LONG-TERM: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL PARENTERAL NUTRITION MARKET BY LONG-TERM 2021−2017 ($ BILLION)
EXHIBIT 53 INCREMENTAL GROWTH BY PATIENT GROUP 2021 & 2027
EXHIBIT 54 GLOBAL PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027
EXHIBIT 55 GLOBAL PARENTERAL NUTRITION BY PATIENT GROUP: MARKET OVERVIEW
EXHIBIT 56 GLOBAL PARENTERAL NUTRITION MARKET BY PATIENT GROUP: INCREMENTAL GROWTH
EXHIBIT 57 GLOBAL PARENTERAL NUTRITION MARKET BY PATIENT GROUP: ABSOLUTE GROWTH
EXHIBIT 58 PRETERM BIRTH STATISTICS 2021
EXHIBIT 59 GLOBAL PARENTERAL NUTRITION MARKET BY PEDIATRIC: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 60 GLOBAL PARENTERAL NUTRITION MARKET BY PEDIATRIC 2021-2022 ($ BILLION)
EXHIBIT 61 GLOBAL PARENTERAL NUTRITION MARKET BY ADULTS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 62 GLOBAL PARENTERAL NUTRITION MARKET BY ADULT 2021−2027 ($ BILLION)
EXHIBIT 63 INCREMENTAL GROWTH BY END-USERS 2021 & 2027
EXHIBIT 64 GLOBAL PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027
EXHIBIT 65 PARENTERAL NUTRITION MARKET BY END-USERS: MARKET OVERVIEW
EXHIBIT 66 GLOBAL PARENTERAL NUTRITION MARKET BY END-USERS: INCREMENTAL GROWTH
EXHIBIT 67 GLOBAL PARENTERAL NUTRITION MARKET BY END-USERS: ABSOLUTE GROWTH
EXHIBIT 68 GLOBAL PARENTERAL NUTRITION MARKET BY HOSPITALS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 69 GLOBAL PARENTERAL NUTRITION MARKET BY HOSPITALS 2021–2027 ($ BILLION)
EXHIBIT 70 GLOBAL PARENTERAL NUTRITION MARKET BY AMBULATORY CARE SETTINGS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 71 GLOBAL PARENTERAL NUTRITION MARKET BY AMBULATORY CARE SETTINGS 2021−2017 ($ BILLION)
EXHIBIT 72 GLOBAL PARENTERAL NUTRITION MARKET BY OTHERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 73 GLOBAL PARENTERAL NUTRITION MARKET BY OTHERS 2021−2017 ($ BILLION)
EXHIBIT 74 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 75 GLOBAL PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027
EXHIBIT 76 PARENTERAL NUTRITION MARKET BY GEOGRAPHY: MARKET OVERVIEW
EXHIBIT 77 GLOBAL PARENTERAL NUTRITION MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 78 GLOBAL PARENTERAL NUTRITION MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 79 BURDEN OF MALNUTRITION: INFANT & YOUNG CHILD NUTRITION STATUS IN NORTH AMERICA 2015 TO 2020 (% RATE).
EXHIBIT 80 NORTH AMERICA PARENTERAL NUTRITION MARKET: KEY COUNTRIES
EXHIBIT 81 NORTH AMERICA PARENTERAL NUTRITION MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 82 PARENTERAL NUTRITION MARKET IN NORTH AMERICA 2021–2027 ($ BILLION)
EXHIBIT 83 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 84 HOSPITALIZED PATIENTS AND MALNUTRITION SEVERITY IN US (2020)
EXHIBIT 85 PARENTERAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 86 PARENTERAL NUTRITION MARKET IN CANADA 2021−2027 ($ BILLION)
EXHIBIT 87 APAC PARENTERAL NUTRITION MARKET: KEY COUNTRIES
EXHIBIT 88 PARENTERAL NUTRITION MARKET IN APAC: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 89 PARENTERAL NUTRITION MARKET IN APAC 2021−2027 ($ BILLION)
EXHIBIT 90 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 91 PARENTERAL NUTRITION MARKET IN CHINA 2021−2027 ($ BILLION)
EXHIBIT 92 PARENTERAL NUTRITION MARKET IN JAPAN 2021−2027 ($ BILLION)
EXHIBIT 93 PARENTERAL NUTRITION MARKET IN INDIA 2021−2027 ($ BILLION)
EXHIBIT 94 PARENTERAL NUTRITION MARKET IN SOUTH KOREA 2021−2027 ($ BILLION)
EXHIBIT 95 PARENTERAL NUTRITION MARKET IN AUSTRALIA 2021−2027 ($ BILLION)
EXHIBIT 96 EUROPE PARENTERAL NUTRITION MARKET: KEY COUNTRIES
EXHIBIT 97 EUROPE TARGET PATIENT POPULATION FOR PARENTERAL NUTRITION
EXHIBIT 98 PARENTERAL NUTRITION MARKET IN EUROPE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 99 PARENTERAL NUTRITION MARKET IN EUROPE 2021–2027 ($ BILLION)
EXHIBIT 100 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 101 PARENTERAL NUTRITION MARKET IN GERMANY 2021−2027 ($ BILLION)
EXHIBIT 102 PEDIATRIC HOME PARENTERAL NUTRITION PATIENT POPULATION IN FRANCE 2021 (%)
EXHIBIT 103 PARENTERAL NUTRITION MARKET IN FRANCE 2021−2027 ($ BILLION)
EXHIBIT 104 PARENTERAL NUTRITION MARKET IN UK 2021−2027 ($ BILLION)
EXHIBIT 105 PARENTERAL NUTRITION MARKET IN ITALY 2021−2027 ($ BILLION)
EXHIBIT 106 DISEASE-RELATED MALNUTRITION PREVALENCE IN HOSPITAL PATIENTS IN SPAIN 2021 (%)
EXHIBIT 107 PARENTERAL NUTRITION MARKET IN SPAIN 2021−2027 ($ BILLION)
EXHIBIT 108 LATIN AMERICA PARENTERAL NUTRITION MARKET: KEY COUNTRIES
EXHIBIT 109 PARENTERAL NUTRITION MARKET IN LATIN AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 110 PARENTERAL NUTRITION MARKET IN LATIN AMERICA 2021–2027 ($ BILLION)
EXHIBIT 111 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 112 PARENTERAL NUTRITION MARKET IN BRAZIL 2021−2027 ($ BILLION)
EXHIBIT 113 PARENTERAL NUTRITION MARKET IN MEXICO 2021−2027 ($ BILLION)
EXHIBIT 114 PARENTERAL NUTRITION MARKET IN ARGENTINA 2021−2027 ($ BILLION)
EXHIBIT 115 PARENTERAL NUTRITION MARKET IN MIDDLE EAST & AFRICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 116 MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET: KEY COUNTRIES
EXHIBIT 117 PARENTERAL NUTRITION MARKET IN MIDDLE EAST & AFRICA 2021–2027 ($ BILLION)
EXHIBIT 118 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 119 PARENTERAL NUTRITION MARKET IN TURKEY 2021−2027 ($ BILLION)
EXHIBIT 120 PARENTERAL NUTRITION MARKET IN SOUTH AFRICA 2021−2027 ($ BILLION)
EXHIBIT 121 SAUDI ARABIA HOSPITALS WITH AVAILABLE TOTAL PARENTERAL NUTRITION SERVICES AND SOLUTIONS IN 2022
EXHIBIT 122 PARENTERAL NUTRITION MARKET IN SAUDI ARABIA 2021−2027 ($ BILLION)
EXHIBIT 123 VENDORS OFFERING PARENTERAL NUTRITION: MARKET DOMINANCE ANALYSIS
EXHIBIT 124 VENDORS OFFERING PARENTERAL NUTRITION: CAPABILITIES & EXPERT ASSESSMENT
EXHIBIT 125 BAXTER ANNUAL REVENUE 2019−2021 ($ MILLION)
EXHIBIT 126 B. BRAUN MELSUNGEN REVENUE 2019−2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 GLOBAL MACRONUTRIENTS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 4 GLOBAL MACRONUTRIENTS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 5 GLOBAL AUTOMATED COMPOUNDS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 6 GLOBAL AUTOMATED COMPOUNDS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 7 GLOBAL MICRONUTRIENTS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 8 GLOBAL MICRONUTRIENTS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 9 GLOBAL SHORT-TERM PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 10 GLOBAL SHORT-TERM PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 11 GLOBAL LONG-TERM PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 12 GLOBAL LONG-TERM PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 13 GLOBAL PEDIATRIC PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 14 GLOBAL PEDIATRIC PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 15 GLOBAL ADULT PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 16 GLOBAL ADULT PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 17 GLOBAL HOSPITALS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 18 GLOBAL HOSPITALS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 19 GLOBAL AMBULATORY CARE SETTINGS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 20 GLOBAL AMBULATORY CARE SETTINGS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 21 GLOBAL OTHERS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 22 GLOBAL OTHERS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 23 NORTH AMERICA PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021−2027 ($ BILLION)
TABLE 24 NORTH AMERICA PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021−2027 (%)
TABLE 25 NORTH AMERICA PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027 ($ BILLION)
TABLE 26 NORTH AMERICA PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027 (%)
TABLE 27 NORTH AMERICA PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 28 NORTH AMERICA PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027 (%)
TABLE 29 NORTH AMERICA PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027 ($ BILLION)
TABLE 30 NORTH AMERICA PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027 2021−2027 (%)
TABLE 31 APAC PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021−2027 ($ BILLION)
TABLE 32 APAC PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021−2027 (%)
TABLE 33 APAC PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027 ($ BILLION)
TABLE 34 APAC PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027 (%)
TABLE 35 APAC PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 36 APAC PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027 (%)
TABLE 37 APAC PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027 ($ BILLION)
TABLE 38 APAC PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027 (%)
TABLE 39 EUROPE PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021−2027 ($ BILLION)
TABLE 40 EUROPE PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021−2027 (%)
TABLE 41 EUROPE PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027 ($ BILLION)
TABLE 42 EUROPE PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027 (%)
TABLE 43 EUROPE PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 44 EUROPE PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027 (%)
TABLE 45 EUROPE PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027 ($ BILLION)
TABLE 46 EUROPE PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027 (%)
TABLE 47 LATIN AMERICA PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021−2027 ($ BILLION)
TABLE 48 LATIN AMERICA PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021−2027 (%)
TABLE 49 LATIN AMERICA PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027 ($ BILLION)
TABLE 50 LATIN AMERICA PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027 (%)
TABLE 51 LATIN AMERICA PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 52 LATIN AMERICA PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027 (%)
TABLE 53 LATIN AMERICA PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027 ($ BILLION)
TABLE 54 LATIN AMERICA PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027 (%)
TABLE 55 MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021−2027 ($ BILLION)
TABLE 56 MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021−2027 (%)
TABLE 57 MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027 ($ BILLION)
TABLE 58 MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027 (%)
TABLE 59 MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 60 MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027 (%)
TABLE 61 MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027 ($ BILLION)
TABLE 62 MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027 (%)
TABLE 63 BAXTER: MAJOR PRODUCT OFFERINGS
TABLE 64 B. BRAUN MELSUNGEN AG: MAJOR PRODUCT OFFERINGS
TABLE 65 FRESENIUS KABI: MAJOR PRODUCT OFFERINGS
TABLE 66 JW PHARMACEUTICALS: MAJOR PRODUCT OFFERINGS
TABLE 67 SICHUAN KELUN PHARMACEUTICALS CO., LTD.: MAJOR PRODUCT OFFERINGS
TABLE 68 ACULIFE: MAJOR PRODUCT OFFERINGS
TABLE 69 ALBERT DAVID: MAJOR PRODUCT OFFERINGS
TABLE 70 AMANTA HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 71 AMERICAN REAGENT: MAJOR PRODUCT OFFERINGS
TABLE 72 BML PARENTERAL DRUGS: MAJOR PRODUCT OFFERINGS
TABLE 73 CARITAS HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 74 EUROFARMA: MAJOR PRODUCT OFFERINGS
TABLE 75 EUROLIFE HEALTHCARE PVT. LTD.: MAJOR PRODUCT OFFERINGS
TABLE 76 FARMOTERAPICA: MAJOR PRODUCT OFFERINGS
TABLE 77 GRIFOLS S.A.: MAJOR PRODUCT OFFERINGS
TABLE 78 ICU MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 79 OTSUKA PHARMACEUTICAL: MAJOR PRODUCT OFFERINGS
TABLE 80 SOLEO HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 81 REVIV: MAJOR PRODUCT OFFERINGS
TABLE 82 PFIZER: MAJOR PRODUCT OFFERINGS
TABLE 83 VIFOR PHARMA: MAJOR PRODUCT OFFERINGS
TABLE 84 GLOBAL PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 85 GLOBAL PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 86 GLOBAL PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021−2027 ($ BILLION)
TABLE 87 GLOBAL PARENTERAL NUTRITION MARKET BY NUTRIENTS 2021−2027 (%)
TABLE 88 GLOBAL PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027 ($ BILLION)
TABLE 89 GLOBAL PARENTERAL NUTRITION MARKET BY INDICATION 2021−2027 (%)
TABLE 90 GLOBAL PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027 ($ BILLION)
TABLE 91 GLOBAL PARENTERAL NUTRITION MARKET BY PATIENT GROUP 2021−2027 (%)
TABLE 92 GLOBAL PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027 ($ BILLION)
TABLE 93 GLOBAL PARENTERAL NUTRITION MARKET BY END-USERS 2021−2027 (%)
TABLE 94 GLOBAL MACRONUTRIENTS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 95 GLOBAL MACRONUTRIENTS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 96 GLOBAL AUTOMATED COMPOUNDS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 97 GLOBAL AUTOMATED COMPOUNDS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 98 GLOBAL MICRONUTRIENTS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 99 GLOBAL MICRONUTRIENTS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 100 GLOBAL SHORT-TERM PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 101 GLOBAL SHORT-TERM PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 102 GLOBAL LONG-TERM PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 103 GLOBAL LONG-TERM PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 104 GLOBAL PEDIATRIC PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 105 GLOBAL PEDIATRIC PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 106 GLOBAL ADULT PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 107 GLOBAL ADULT PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 108 GLOBAL HOSPITALS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 109 GLOBAL HOSPITALS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 110 GLOBAL AMBULATORY CARE CENTERS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 111 GLOBAL AMBULATORY CARE CENTERS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 112 GLOBAL OTHERS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 113 GLOBAL OTHERS PARENTERAL NUTRITION MARKET BY GEOGRAPHY 2021−2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
